Teleflex Celebrates Strong Dividend Declaration for Investors

Teleflex Declares Quarterly Dividend

Teleflex Incorporated (NYSE: TFX), based in Wayne, Pennsylvania, has proudly announced a quarterly cash dividend of $0.34 per share of its common stock. This declaration is a testament to the company's ongoing commitment to providing value to its shareholders. The dividend will be payable on March 17 to those shareholders who are on record as of March 7. Such initiatives reflect Teleflex's strong financial performance and its dedication to returning capital to its investors.

Commitment to Shareholders

At Teleflex, we understand that dividends are an important part of the total return for many investors. By declaring this dividend, we are continuing our tradition of rewarding our shareholders and demonstrating confidence in our business strategy and operational performance. Teleflex continues to explore avenues for sustainable growth and profitability, ensuring we not only achieve but exceed our shareholders' expectations.

A Leader in Medical Technology

Teleflex is more than just a company that pays dividends; it is a leading global provider of medical technologies dedicated to enhancing the health and quality of people’s lives. With a clear vision to become the most trusted healthcare partner, Teleflex offers a robust portfolio of solutions across various medical therapy areas such as anesthesia, emergency medicine, interventional cardiology and radiology, as well as surgical, vascular access, and urology.

Diverse Portfolio of Trusted Brands

Among the well-known brands under the Teleflex umbrella are Arrow™, Barrigel™, Deknatel™, LMA™, Pilling™, QuikClot™, Rüsch™, UroLift™, and Weck™. These brands are united by a common purpose: to develop innovative solutions for healthcare providers and patients alike. This diverse portfolio underscores Teleflex's commitment to advancing healthcare while addressing some of the critical challenges in the medical field.

Investing in the Future

As Teleflex continues its journey, the focus remains sharply on empowering the future of healthcare. The company is committed to investing in research and development to foster purpose-driven innovation that can lead to groundbreaking advancements in medical technology. Our goal is not only to enhance our product offerings but also to ensure that healthcare systems worldwide can leverage our solutions effectively.

Continuous Improvement and Innovation

Each product developed by Teleflex is the result of extensive research and collaboration with healthcare professionals. This approach ensures that every solution is carefully engineered to meet the growing and evolving needs of patients and providers. The team's commitment to quality and safety is evident in every stage of product development, reinforcing Teleflex's reputation in the industry.

Contact Information

For any inquiries or further details, please reach out to the Teleflex Investor Relations team:

Teleflex
Lawrence Keusch
Vice President, Investor Relations and Strategy Development
Email: investor.relations@teleflex.com
Phone: 610-948-2836

Frequently Asked Questions

What is the amount of the declared dividend by Teleflex?

The declared dividend by Teleflex is $0.34 per share of common stock.

When will the dividend be paid?

The dividend is scheduled to be paid on March 17 to shareholders on record as of March 7.

What are some of the key brands owned by Teleflex?

Teleflex owns several trusted brands including Arrow™, LMA™, and QuikClot™.

How does Teleflex support healthcare innovation?

Teleflex invests in research and development to create innovative medical technologies that improve patient care.

Whom can I contact for investor relations at Teleflex?

You can contact Lawrence Keusch, Vice President of Investor Relations, at investor.relations@teleflex.com or call 610-948-2836.

About The Author

Olivia Taylor here, a 26-year-old writer and financial advisor. After earning a degree in finance, I worked in the sector for years. I've always loved numbers and had a talent for simplifying difficult financial ideas so that anyone could understand. I wrote my first book because of this passion; it helps readers take charge of their financial futures by fusing real-life stories with useful financial advice.

Whether they are just beginning their careers, preparing for significant life events, or seeking to invest wisely, my goal with my writing is to enable people to make educated financial decisions. The foundation of my work is the conviction that security and freedom of the individual are largely determined by financial literacy. To further financial education, I run workshops and frequently write for financial blogs in addition to my books.

I like to travel, experience other cultures, and find inspiration in daily life when I'm not writing or examining market trends. My passion is utilizing sound financial practices to help people reach their financial objectives and lead the best lives possible.

Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.